Search results for: infliximab

Coding Corner Questions: January

Staff | January 1, 2015

Coding cases of drug-induced gout, systemic lupus erythematosus with lung involvement, inflammatory rheumatoid arthritis, osteoporosis

Rick Brasington, MD | January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Peter H. Schur, MD | December 1, 2014

A review of data on antinuclear antibodies and tests for rheumatoid arthritis

How to manage the risks when prescribing medications for patients in chronic pain

Staff | December 1, 2014

Referred to as -X modifiers, they are designed to define specific subsets of -59 modifier

Jared H. Brock, BS, Blaine M. Hannafin, MD, RDMS, & Frank Lovecchio, DO, MPH | October 1, 2014

A 65-year-old man presents with symptoms of erythrodermic psoriasis flare

Staff | September 1, 2014

Coding for first infliximab infusion in patient with rheumatoid arthritis

Staff | September 1, 2014

Coding for first infliximab infusion in patient with rheumatoid arthritis

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA